THE STRUCTURAL HEART DISEASE SUMMIT 2018

Overview

Careers

Overview

LAA and PFO Closure - Interventional Prevention of Cardioembolic Stroke: A Technique-Oriented Course will provide cardiologists and other healthcare providers with the latest information on the technologies, indications, and outcomes of left atrial appendage (LAA) and patent foramen ovale (PFO) closure to prevent cardioembolic stroke. Live cases will be performed by experts in the field to demonstrate firsthand basic and advanced techniques of LAA and PFO closure. Imaging for preprocedural planning and procedural guidance will be emphasized. This course is designed to provide an overview of all treatment modalities—from current clinical data to how to perform the procedure—and methods to work through any complications in order to provide better care to patients.


The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Documentation of awarded credit is provided for registered attendees in exchange for completed activity evaluations. Certificates of attendance and CME certificates available on the CRF events app and online at cme.crf.org.

By the end of this course, participants will be able to:

  • Describe the indications for and outcomes of LAA and PFO closure to prevent stroke
  • Explain the devices, technology, and basic techniques of LAA and PFO closure
  • Understand the imaging guidance of LAA and PFO closure, trans-septal puncture, device sizing and placement, and determinations of success
  • Discuss the clinical results of current and future trials of LAA and PFO closure
  • Describe the tips and tricks of setting up a cardioembolic stroke prevention program

Who is this course for?

Interventional cardiologists, general cardiologists, cardiology fellows, catheterization laboratory technicians, and other healthcare professionals interested in learning the latest indications, devices, techniques, and outcomes for the prevention of cardioembolic stroke by LAA and PFO closure.

Evaluation will address content, presentation, possible bias, and future educational needs.

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.

Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.